Australia markets closed

Salarius Pharmaceuticals Inc (FP1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.4260-0.0080 (-1.86%)
As of 02:10PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
5,233
-
Operating expenses
Research development
3,691
7,174
15,837
8,549
6,914
-
Selling general and administrative
5,555
5,721
7,138
6,105
6,106
-
Total operating expenses
9,246
12,895
22,975
12,813
12,844
-
Operating income or loss
-9,246
-12,895
-22,975
-12,813
-7,611
-
Total other income/expenses net
-
-
-8,851
44.693
258.551
1,311
Income before tax
-8,917
-12,543
-31,608
-12,768
-7,352
-
Income from continuing operations
-8,917
-12,543
-31,608
-12,768
-7,352
-
Net income
-8,917
-12,543
-31,608
-12,768
-7,352
-
Net income available to common shareholders
-8,917
-12,543
-31,608
-12,768
-7,749
-
Basic EPS
-6.59
-3.84
-14.88
-7.72
-12.50
-
Diluted EPS
-6.59
-3.84
-14.88
-7.72
-12.50
-
Basic average shares
2,842
3,265
2,125
1,655
623.144
-
Diluted average shares
2,842
3,265
2,125
1,655
623.144
-